Should there be an age limit for advanced therapies?

Area of Science:

• Cardiovascular Surgery
• Thoracic Surgery
• Transplantation Medicine

Background:

• Combined heart and lung transplantation is an infrequent procedure.
• A notable patient cohort could benefit from simultaneous heart and lung replacement.
• This patient group is highly heterogeneous.

Purpose of the Study:

• To highlight the importance of individualized patient selection for combined heart and lung transplants.
• To emphasize the need for tailored evaluation strategies in this diverse population.
• To discuss the role of age as a risk factor in combined heart and lung transplantation.

Main Methods:

• Review of current practices and outcomes in combined heart and lung transplantation.
• Analysis of patient characteristics influencing transplant candidacy.
• Integration of age-specific risk assessment into perioperative and long-term evaluations.

Main Results:

• Patient selection criteria must be adapted to individual patient needs and specific clinical circumstances.
• Age is a potential risk factor that requires careful consideration.
• Perioperative and long-term risks associated with combined heart and lung transplantation vary significantly among patients.

Conclusions:

• Individualized assessment is paramount for selecting appropriate candidates for combined heart and lung transplantation.
• Age should be judiciously incorporated into risk evaluations for combined heart and lung transplant candidates.
• Optimizing patient selection can improve outcomes for this complex procedure.